Get the Stockscreener App
3.11
0.32%
0.010
Protara Therapeutics Inc stock is traded at $3.11, with a volume of 222.84K.
It is up +0.32% in the last 24 hours and down -6.61% over the past month.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
See More
Previous Close:
$3.10
Open:
$3.13
24h Volume:
222.84K
Relative Volume:
0.73
Market Cap:
$119.99M
Revenue:
-
Net Income/Loss:
$-42.05M
P/E Ratio:
-1.1028
EPS:
-2.82
Net Cash Flow:
$-35.26M
1W Performance:
+2.64%
1M Performance:
-6.61%
6M Performance:
-16.40%
1Y Performance:
+46.01%
1-Day Range:
$3.09
$3.27
1-Week Range:
$2.97
$3.27
52-Week Range:
$1.595
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
Name
Protara Therapeutics Inc
Sector
Industry
Phone
646-844-0337
Address
345 PARK AVENUE SOUTH, NEW YORK, NY
Compare TARA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
3.11 | 124.23M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-16-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-14-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-10-23 | Resumed | Guggenheim | Buy |
| Jun-04-21 | Initiated | H.C. Wainwright | Buy |
| Feb-17-21 | Initiated | Oppenheimer | Outperform |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Jul-29-20 | Initiated | Guggenheim | Buy |
View All
Protara Therapeutics Inc Stock (TARA) Latest News
Protara Therapeutics Inc. recovery potential after sell offInsider Buying & Safe Capital Investment Plans - Newser
Using data tools to time your Protara Therapeutics Inc. exitWeekly Stock Report & Fast Gaining Stock Reports - Newser
How Protara Therapeutics Inc. stock performs during market volatility2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - Newser
Is now a turning point for Protara Therapeutics Inc.2025 Technical Patterns & Real-Time Buy Signal Notifications - Newser
Using economic indicators to assess Protara Therapeutics Inc. potentialJuly 2025 Technicals & Smart Allocation Stock Tips - Newser
Chart overlay techniques for tracking Protara Therapeutics Inc.July 2025 Highlights & Entry Point Confirmation Signals - Newser
Combining machine learning predictions for Protara Therapeutics Inc.Weekly Loss Report & Reliable Intraday Trade Plans - Newser
Applying big data sentiment scoring on Protara Therapeutics Inc.July 2025 Snapshot & Safe Capital Investment Plans - Newser
Can volume confirm reversal in Protara Therapeutics Inc.July 2025 Fed Impact & High Yield Equity Trading Tips - Newser
What’s the recovery path for long term holders of Protara Therapeutics Inc.Market Volume Report & Stock Timing and Entry Methods - Newser
Does Protara Therapeutics Inc. fit your quant trading modelTrade Volume Summary & Reliable Price Breakout Alerts - Newser
How to track smart money flows in Protara Therapeutics Inc.Jobs Report & AI Forecast Swing Trade Picks - Newser
Is Protara Therapeutics Inc. stock poised for growthWeekly Trend Summary & Technical Entry and Exit Tips - Newser
Published on: 2025-08-19 04:42:29 - Newser
Analysts Offer Insights on Healthcare Companies: Protara Therapeutics (TARA), Annexon Biosciences (ANNX) and Agilent (A) - The Globe and Mail
Protara Therapeutics, Inc. (NASDAQ:TARA) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Strategies to average down on Protara Therapeutics Inc.Portfolio Return Summary & Safe Entry Zone Identification - Newser
Tick level data insight on Protara Therapeutics Inc. volatilityQuarterly Profit Report & Real-Time Volume Analysis - Newser
Smart tools for monitoring Protara Therapeutics Inc.’s price actionEarnings Summary Report & Weekly Top Gainers Alerts - Newser
Backtesting results for Protara Therapeutics Inc. trading strategiesAnalyst Upgrade & Real-Time Stock Entry Alerts - Newser
Is Protara Therapeutics Inc. a play on infrastructure spendingExit Point & Real-Time Buy Signal Notifications - thegnnews.com
What earnings revisions data tells us about Protara Therapeutics Inc.Risk Management & Consistent Profit Alerts - Newser
Can Protara Therapeutics Inc. ride the EV waveOil Prices & Low Drawdown Trading Strategies - sundaytimes.kr
Using data filters to optimize entry into Protara Therapeutics Inc.July 2025 Institutional & Weekly Breakout Watchlists - Newser
Using RSI to spot recovery in Protara Therapeutics Inc.Trade Analysis Report & Real-Time Volume Surge Alerts - Newser
Is Protara Therapeutics Inc. in a bullish channelJuly 2025 Rallies & Precise Swing Trade Entry Alerts - thegnnews.com
Drawdown in Protara Therapeutics Inc. May Be Nearing EndQuarterly Earnings Report & Accurate Intraday Trading Signals - 선데이타임즈
Protara Therapeutics Inc. stock volume spike explainedJuly 2025 Pullbacks & Free Safe Capital Growth Stock Tips - Newser
Why Protara Therapeutics Inc. stock attracts strong analyst attention2025 Investor Takeaways & Community Trade Idea Sharing Platform - thegnnews.com
HC Wainwright Issues Positive Estimate for TARA Earnings - Defense World
Protara Therapeutics Inc Stock (TARA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Protara Therapeutics Inc Stock (TARA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Zummo Jacqueline | Chf Scientific Operations Off |
Mar 26 '25 |
Sale |
4.53 |
21,224 |
96,145 |
98,861 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):